Managing Director statement

I have been working at QPharma since 2008 and it is a great company! There are so many opportunities to do new things and we have excellent, professional staff sharing the same interest: to reach our company goals and have fun in the process.

I believe that people like to work at QPharma because we are constantly making positive and interesting achievements, and there is an overall family feeling with an international touch.

The company has been growing steadily for many years, mainly thanks to our customers, who strongly believe in QPharma and who we work very closely with to reach our common goals. I am convinced that QPharma will continue to grow even faster in the coming years. Right now, we are expanding sales, staff, facilities and our product portfolio. Our area of focus is high potent development and production, in particular within the area of controlled release.

QPharma has invested heavily in buildings and equipment with the aim of supporting growth and widening our core capabilities. A new factory for high potent production was built in 2013 and now in 2018 we are doubling its size to accommodate new interesting products. A newly built full scale extrusion line for high potent production supports the development and production of our niche products, vaginal rings and implants. We are also increasing our capacity to assemble auto-injectors by setting up a new high speed line.

Our customers are mostly international pharma companies of all sizes as well as several non-profit organisations. I am particularly proud to know that several of our products and projects will improve women’s health around the world.

David Segerberg
Managing Director